Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

266 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sequential therapy with sorafenib and sunitinib in renal cell carcinoma.
Dudek AZ, Zolnierek J, Dham A, Lindgren BR, Szczylik C. Dudek AZ, et al. Among authors: szczylik c. Cancer. 2009 Jan 1;115(1):61-7. doi: 10.1002/cncr.24009. Cancer. 2009. PMID: 19051290
Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines.
Bodnar L, Stec R, Cierniak S, Synowiec A, Wcisło G, Jesiotr M, Koktysz R, Kozłowski W, Szczylik C. Bodnar L, et al. Among authors: szczylik c. Ann Oncol. 2015 Jul;26(7):1385-9. doi: 10.1093/annonc/mdv166. Epub 2015 May 10. Ann Oncol. 2015. PMID: 25962440 Clinical Trial.
Multimodality treatment of germ cell cancer patients who had progression or relapse after high dose chemotherapy and autologous bone marrow transplantation.
Sarosiek T, Rzepecki P, Langiewicz P, Zolnierek J, Barzal J, Szczylik C. Sarosiek T, et al. Among authors: szczylik c. J BUON. 2007 Jul-Sep;12(3):335-40. J BUON. 2007. PMID: 17918286
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial.
Fuchs CS, Azevedo S, Okusaka T, Van Laethem JL, Lipton LR, Riess H, Szczylik C, Moore MJ, Peeters M, Bodoky G, Ikeda M, Melichar B, Nemecek R, Ohkawa S, Świeboda-Sadlej A, Tjulandin SA, Van Cutsem E, Loberg R, Haddad V, Gansert JL, Bach BA, Carrato A. Fuchs CS, et al. Among authors: szczylik c. Ann Oncol. 2015 May;26(5):921-927. doi: 10.1093/annonc/mdv027. Epub 2015 Jan 21. Ann Oncol. 2015. PMID: 25609246 Free PMC article. Clinical Trial.
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings.
Beck J, Procopio G, Bajetta E, Keilholz U, Negrier S, Szczylik C, Bokemeyer C, Bracarda S, Richel DJ, Staehler M, Strauss UP, Mersmann S, Burock K, Escudier B. Beck J, et al. Among authors: szczylik c. Ann Oncol. 2011 Aug;22(8):1812-23. doi: 10.1093/annonc/mdq651. Epub 2011 Feb 15. Ann Oncol. 2011. PMID: 21324953 Clinical Trial.
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma.
Melichar B, Koralewski P, Ravaud A, Pluzanska A, Bracarda S, Szczylik C, Chevreau C, Filipek M, Delva R, Sevin E, Négrier S, McKendrick J, Santoro A, Pisa P, Escudier B. Melichar B, et al. Among authors: szczylik c. Ann Oncol. 2008 Aug;19(8):1470-1476. doi: 10.1093/annonc/mdn161. Epub 2008 Apr 11. Ann Oncol. 2008. PMID: 18408224 Clinical Trial.
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring P, Hawkins RE, Crinò L, Kim TM, Carteni G, Eberhardt WE, Zhang K, Fly K, Matczak E, Lechuga MJ, Hariharan S, Bukowski R. Gore ME, et al. Among authors: szczylik c. Br J Cancer. 2015 Jun 30;113(1):12-9. doi: 10.1038/bjc.2015.196. Epub 2015 Jun 18. Br J Cancer. 2015. PMID: 26086878 Free PMC article.
Insulin and IGFs in renal cancer risk and progression.
Solarek W, Czarnecka AM, Escudier B, Bielecka ZF, Lian F, Szczylik C. Solarek W, et al. Among authors: szczylik c. Endocr Relat Cancer. 2015 Oct;22(5):R253-64. doi: 10.1530/ERC-15-0135. Endocr Relat Cancer. 2015. PMID: 26330483 Review.
Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?
Górnaś M, Szczylik C. Górnaś M, et al. Among authors: szczylik c. Eur J Cancer Care (Engl). 2010 Jan 1;19(1):131-6. doi: 10.1111/j.1365-2354.2008.00999.x. Epub 2009 Jul 20. Eur J Cancer Care (Engl). 2010. PMID: 19686351
Pharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern Europe.
Vrdoljak E, Torday L, Szczylik C, Kharkevich G, Bavbek S, Sella A. Vrdoljak E, et al. Among authors: szczylik c. Expert Opin Pharmacother. 2016;17(1):93-104. doi: 10.1517/14656566.2016.1107043. Epub 2015 Nov 30. Expert Opin Pharmacother. 2016. PMID: 26619144
266 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback